Page 2442 - Williams Hematology ( PDFDrive )

2413
2412 Index Index 2413

CEPBA, 1280, 1377, 1378t, 1379, 1383 eosinophil, 950–951, 951t red cell transfusion in, 2371
Cephalosporins, 830 monocytes, 1057–1058, 1058t, 1080t reference ranges for blood examination,
Cerebral thrombosis, 1519–1520, 1520f Chemokines 15t
Cerebrovascular disease. See Stroke cellular homing and, 68–71, 70t Chills, history of, 4
Ceruloplasmin, 621t extracellular matrix, 62t Chimeric antigen receptor T (CAR-T) cells,
Cervix, primary lymphomas in, 1582 in extracellular matrix, 60–61 1539
CFB, 2259t inactivation and sequestration, 285 Chimeric antigen receptor (CAR), 415–416,
CFC (colony-forming cell), 269 in innate immune response, 303 415f, 438, 442, 454, 1193, 1404
CFH, 2259t in regulation of inflammation, 286t, Chimeric proteins, 173
CFI, 2259t 287–288, 288t Chitotriosidase, 1126
CFU (colony-forming unit), 269 Chemotactic receptors, on neutrophils, 934t Chk1 inhibitors, 219
CFU-E. See Colony-forming unit-erythroid Chemotaxis Chlamydia pneumoniae, 2283
(CFU-E) leukocyte, 283–284 Chlamydophila psittaci infection, lymphomas
CFU-GEMM (colony-forming unit- monocytes and macrophages, 1059, 1060t and, 1574, 1579, 1664
granulocyte-erythroid-monocyte neutrophil, 1005 Chlorambucil
macrophage), 100 in newborns, 106 adverse effects, 1534
CFU-GM (colony-forming unit-granulocyte- Chemotherapy. See Antineoplastic drugs/ for autoimmune hemolytic anemia, 839
monocyte), 100, 263 chemotherapy for chronic lymphocytic leukemia, 1534,
CH50, 1232 Chest 1536
Chaenocephalus aceratus, 479 examination, 8 for follicular lymphoma, 1644, 1645t
“Chaperone therapy,” 1128 history of disorders of, 5 for γ-heavy-chain disease, 1806
Charcot-Leyden crystal (CLC) protein, 929, pain, 5, 2295. See also Myocardial for mantle cell lymphoma, 1657t
947, 953 infarction (MI) mechanism of action, 329
CHARGE syndrome, 1223 primary lymphomas in, 1581 for mycosis fungoides, 1687
CHD7, 1222 Chickenpox, 835 for polycythemia vera, 1298t
CHD (chromodomain)-family remodelers, Chido/Rogers blood group, 2331t for Waldenström macroglobulinemia, 1793
166, 166f Children N-Chloramines, 284t
Chédiak-Higashi syndrome, 1018–1020 acute lymphoblastic leukemia in Chloramphenicol
abnormal granules in, 22f, 23, 1843 chromosomal abnormalities, 1508t, aplastic anemia and, 515
clinical features, 994, 1018, 1019t, 1229 1513t for bartonellosis, 818
definition and history, 1018 clinical features, 1509t hemolytic anemia and, 708
differential diagnosis, 1020 development in utero, 1507 Chlorates, erythrocyte damage from, 810
epidemiology, 1018 differential diagnosis, 1513–1514 Chlordane, aplastic anemia and, 517
etiology and pathogenesis, 1018, 1019t, gene mutations, 1508t, 1513t Chlorguanide, megaloblastic anemia and,
1229 incidence, 1506, 1526f 606t
laboratory features, 994, 1018 laboratory features, 1509–1510, 1510t 2-Chloro-2′-fluoro-arabinosyladenine. See
macrophage defects in, 1091 survival, 1506f, 1513t Clofarabine
natural killer cells and, 1192 treatment, 1505, 1515, 1516 2-Chlorodeoxyadenosine. See Cladribine
neutrophil abnormalities in, 984t, 986, acute myelogenous leukemia in, 1380, Chloroma. See Myeloid (granulocytic)
1019t 1409–1410 sarcoma
therapy, 1020, 1229 antiphospholipid syndrome in, 2241 Chloroquine, for porphyria cutanea tarda,
Chelation therapy. See Iron chelation therapy autoimmune neutropenia in, 2358 908
Chemicals bleeding risk in, 2382–2383 Chlorosis, 628
hemolytic anemia caused by, 809–811 chronic myelogenous leukemia in, 1445 Cholesterol crystal emboli, 2101, 2102f, 2298
history of exposure to, 6–7 immune thrombocytopenia in, 2001, 2002t CHOP (C/EBP homologous protein), 204f,
porphyrias caused by, 907 iron deficiency in, 632 205, 208f
Chemokine ligands, 70t juvenile myelomonocytic leukemia in, CHOP regimen. See also R-CHOP regimen
Chemokine receptor (CCR) 1, 1878 1096, 1468t, 1470–1471 for anaplastic large cell lymphoma, 1699
Chemokine receptor (CCR) 2, 1052f, 2286 juvenile xanthogranuloma in, 1101, 1102t, for diffuse large B-cell lymphoma,
Chemokine receptor (CCR) 3, 950, 1878 1111–1112 1628–1630, 1628t, 1629t
Chemokine receptor (CCR) 4, 1878 Langerhans cell histiocytosis in. See for enteropathy-associated T-cell
Chemokine receptor (CCR) 5, 440, 454, 1057, Langerhans cell histiocytosis lymphoma, 1699
1240 lymphocyte subsets, 109t for gastric MALT lymphoma, 1666
Chemokine receptor (CCR) 7, 1183, 1699, megaloblastic anemia in, 605, 607 for HIV-associated lymphoma, 1245
1710 paroxysmal nocturnal hemoglobinuria in, for mantle cell lymphoma, 1655, 1657t
Chemokine receptors (CCRs), 70t 580 for NK/T-cell lymphoma, 1702

Kaushansky_index_p2393-2506.indd 2413 9/21/15 3:21 PM